1577 related articles for article (PubMed ID: 26026972)
41. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
Yang YS; Ku CH; Lin JC; Shang ST; Chiu CH; Yeh KM; Lin CC; Chang FY
J Microbiol Immunol Infect; 2010 Jun; 43(3):194-9. PubMed ID: 21291846
[TBL] [Abstract][Full Text] [Related]
42. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012).
Lai B; Zheng B; Li Y; Zhu S; Tong Z
BMC Infect Dis; 2014 Feb; 14():66. PubMed ID: 24502648
[TBL] [Abstract][Full Text] [Related]
43. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
He XT; Chang CN; Yu CH; Wang CC
Pediatr Neonatol; 2024 May; 65(3):242-248. PubMed ID: 37951832
[TBL] [Abstract][Full Text] [Related]
44. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
Kiremitci A; Dinleyici EC; Erben N; Durmaz G; Yargic ZA; Aybey AD; Usluer G
Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776
[TBL] [Abstract][Full Text] [Related]
45. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
[TBL] [Abstract][Full Text] [Related]
46. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
47. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
Hernández JR; Pascual A; Cantón R; Martínez-Martínez L;
Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):77-82. PubMed ID: 12586030
[TBL] [Abstract][Full Text] [Related]
48. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
[TBL] [Abstract][Full Text] [Related]
49. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children.
Kizilca O; Siraneci R; Yilmaz A; Hatipoglu N; Ozturk E; Kiyak A; Ozkok D
Pediatr Int; 2012 Dec; 54(6):858-62. PubMed ID: 22882781
[TBL] [Abstract][Full Text] [Related]
51. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Bishara J; Livne G; Ashkenazi S; Levy I; Pitlik S; Ofir O; Lev B; Samra Z
Isr Med Assoc J; 2005 May; 7(5):298-301. PubMed ID: 15909461
[TBL] [Abstract][Full Text] [Related]
52. In vitro activity of three different antimicrobial agents against ESBL producing Escherichia coli and Klebsiella pneumoniae blood isolates.
Kizirgil A; Demirdag K; Ozden M; Bulut Y; Yakupogullari Y; Toraman ZA
Microbiol Res; 2005; 160(2):135-40. PubMed ID: 15881830
[TBL] [Abstract][Full Text] [Related]
53. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
Bazzaz BS; Naderinasab M; Mohamadpoor AH; Farshadzadeh Z; Ahmadi S; Yousefi F
Acta Microbiol Immunol Hung; 2009 Mar; 56(1):89-99. PubMed ID: 19388560
[TBL] [Abstract][Full Text] [Related]
54. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
[TBL] [Abstract][Full Text] [Related]
55. Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
Wang Y; Zhang Q; Jin Y; Jin X; Yu J; Wang K
Braz J Microbiol; 2019 Jul; 50(3):669-675. PubMed ID: 30972583
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
57. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
[TBL] [Abstract][Full Text] [Related]
58. Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
Cholley P; Thouverez M; Gbaguidi-Haore H; Sauget M; Slekovec C; Bertrand X; Talon D; Hocquet D
Med Mal Infect; 2013 Aug; 43(8):331-6. PubMed ID: 23876202
[TBL] [Abstract][Full Text] [Related]
59. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.
Wollheim C; Guerra IM; Conte VD; Hoffman SP; Schreiner FJ; Delamare AP; Barth AL; Echeverrigaray S; Costa SO
Braz J Infect Dis; 2011; 15(2):138-43. PubMed ID: 21503400
[TBL] [Abstract][Full Text] [Related]
60. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
Hamouche E; Sarkis DK
Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
